IPHA
Innate Pharma·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
IPHA Filings
Filing Date
Form Description
Form Type
2025-11-28
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-11-28 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-11-17
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-11-17 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-11-13
Innate Pharma S.A. (IPHA) Q3 2025 Earnings Call Transcript
Earnings Call
2025-11-13 · Earnings Call
Innate Pharma S.A. (IPHA) Q3 2025 Earnings Call Transcript
2025-11-13
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Financials
2025-11-13 · Financials
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-11-10
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-11-10 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-11-05
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-11-05 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-10-21
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-10-21 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-10-15
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-10-15 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-09-17
Innate Pharma S.A. (IPHA) Q2 2025 Earnings Call Transcript
Earnings Call
2025-09-17 · Earnings Call
Innate Pharma S.A. (IPHA) Q2 2025 Earnings Call Transcript
2025-09-17
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-09-17 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
